Vitex Stock Falls On Enrollment Suspension In Inactine Phase III Nov. 29, 2004 By Holland Johnson No Comments
GE Healthcare calls its Vivid i 'the virtual stethoscope of future' Oct. 1, 2004 By Holland Johnson No Comments
ReValving may change valve replacement and open-heart surgery Aug. 1, 2004 By Holland Johnson No Comments
St. Jude becomes third company with entry in U.S. CRT-D market Aug. 1, 2004 By Holland Johnson No Comments
Two firms' cardiac diagnostic tests are cleared for sale by FDA June 1, 2004 By Holland Johnson No Comments
Guidant CEO Dollens reveals plans to retire by the end of the year June 1, 2004 By Holland Johnson No Comments
NEJM publishes data from two significant heart failure trials June 1, 2004 By Holland Johnson No Comments
GE Healthcare shines spotlight on its growing presence in cardiology May 1, 2004 By Holland Johnson No Comments